The present gold standard, bacterial blood cultures and susceptibility testing, requires days to obtain a result. The initial treatment
with empirical broad-spectrum antibiotics not only is inadequate but also promotes antimicrobial resistance AMR . The high mortality
of sepsis and AMR is partly due to the inability to rapidly detect and identify bacteria in the early stages of infection.
Benefits
directly lead to a rapid, sensitive, and specific test to detect and identify bacterial infection in blood. The test will enable
healthcare providers to prescribe an effective treatment of sepsis during its early stage before it becomes more dangerous.
Biotechnology Industry Research Assistance Council, New Delhi
Quick Information
Thrust Areas
Medical Sciences
Focus Area
Healthcare, Digital Health
Status
Proof of concept
Output
Status
Proof of concept
TRL: Technology Readiness Level
TRL-3
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Siamaf Healthcare Private Limited, Bengaluru, Karnataka
Accessibility Controls